XENE FY 2020 Earnings — Xenon Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

XENEXenon Pharmaceuticals Inc.

$5B

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$32M+371.0% YoY

Gross Profit

$32M100.0% margin

Operating Income

-$31M-97.3% margin

Net Income

-$29M-89.7% margin

EPS (Diluted)

$-0.83

Cash Flow

Operating Cash Flow

-$48M

Free Cash Flow

-$51M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$189M

Total Liabilities

$18M

Stockholders' Equity

$171M

Cash & Equivalents

$45M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$32M	$7M	+371.0%
Gross Profit	$32M	$7M	+371.0%
Operating Income	-$31M	-$43M	+26.9%
Net Income	-$29M	-$42M	+30.7%